Serum cystatin C as a marker of glomerular filtration rate

Current Opinion in Nephrology and Hypertension

Volumn 10, Issue 5, 2001, Pages 551-553

  Dworkin, Lance D ^a,b  

^a BROWN UNIVERSITY   (United States)

^b MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C;

CREATININE CLEARANCE; DIAGNOSTIC VALUE; FUNCTIONAL ASSESSMENT; GLOMERULUS FILTRATION RATE; HUMAN; NOTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

BIOLOGICAL MARKERS; CYSTATINS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS;

EID: 0034866839     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200109000-00001     Document Type: Note

References (33)

1. The kidney: Structure and function in health and disease
2. Studies on kidney function. I: The rate of filtration and reabsorption in the human kidney
3. Serum creatinine as an index of renal function: New insights into old concepts
4. Biological variation of cystatin C: Implications for the assessment of glomerular filtration rate
5. Human cystatin, a new protein inhibitor of cysteine proteinases
6. Structure and expression of the human cystatin C gene
7. Serum cystatin C as an endogenous marker of the renal function-a review
8. The blood serum concentration of cystatin C (gamma-trace) as a measure of glomerular filtration rate
9. 2-micro-globulin as a measure of glomerular filtration rate
10. Relationships among serum cystatin C, serum creatinine, lean tissue mass, and glomerular filtration rate in healthy adults
11. Reference intervals for the glomerular filtration rate and cell-proliferation markers: Serum cystatin C and serum beta 2-microglobulin/cystatin C ratio
12. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children
13. Adult reference ranges for serum cystatin C, creatinine, and predicted creatinine clearance
14. Human gamma-trace, a basic microprotein: Amino acid sequence and presence in the adenohypophysis
15. Renal handling of radiolabelled human cystatin C in the rat
16. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomular filtration rate
17. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II)
18. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes
19. Determination of serum cystatin C in patients with essential hypertension
20. Is serum cystatin C a sensitive marker of glomerular filtration rate (GFR)? A preliminary study on renal transplant patients
21. Rapid and accurate assessement of glomerular filtration rate in patients with renal transplants using serum cystatin C
22. Cystatin C measurement and its practical use in patients with various renal diseases
23. The serum cystatin C concentration measured by particle-enhanced immunonephelometry is well correlated with inulin clearance in patients with various types of glomerulonephritis
24. Correlation of serum concentrations of cystatin C and creatinine in inulin clearance in liver cirrhosis
25. Serum cystatin C concentration as a marker of renal dysfunction in the elderly
26. Improved prediction of decreased creatinine clearance by serum cystatin C: Use in cancer patients before and during chemotherapy
27. Cystatin C: Efficacy as screening test for reduced glomerular filtration rate
28. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Report from the National Kidney Foundation Task Force on Cardiovascular Disease
29. Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis
30. Renal and cardiovascular predictors of 9-year total and sudden cardiac mortality in non-insulin-dependent diabetic subjects
31. Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine
32. Prevention of diabetic nephropathy in normotensive IDDM patients with microalbuminuria
33. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy